Immunopharmacologic effects of cycloleucine.
D000596:Amino Acids / Q000494:pharmacology*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001168:Arthritis / Q000139:chemically induced / Q000188:drug therapy; D001835:Body Weight / Q000187:drug effects; D002464:Cell Migration Inhibition; D002478:Cells, Cultured; D003517:Cyclopentanes / Q000494:pharmacology*; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000139:chemically induced / Q000188:drug therapy; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007930:Leucine / Q000008:administration & dosage; D007962:Leukocytes / Q000187:drug effects; D008297:Male; D008851:Micropore Filters; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors; D014633:Valine / Q000037:antagonists & inhibitors
D000596:Amino Acids; D000893:Anti-Inflammatory Agents; D003517:Cyclopentanes; D007166:Immunosuppressive Agents; D007930:Leucine; D014633:Valine